Known targets — ChEMBL curated mechanism
ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 known ✓ | P00915 | 2/20 | 0.40 |
| ▸ | CA2 known ✓ | P00918 | 2/20 | 0.40 |
| ▸ | CA12 known ✓ | O43570 | 1/20 | 0.40 |
| ▸ | ESR2 known ✓ | Q92731 | 1/20 | 0.39 |
| ▸ | ALOX5 known ✓ | P09917 | 1/20 | 0.38 |
| ▸ | HSD17B3 | P37058 | 1/20 | 0.45 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.44 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.44 |
| ▸ | HSP90AB1 | P08238 | 1/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.43 |
| ▸ | HTT | P42858 | 2/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.40 |
| ▸ | NPC1 | O15118 | 1/20 | 0.40 |
| ▸ | CASP3 | P42574 | 1/20 | 0.40 |
| ▸ | RAB9A | P51151 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.40 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.40 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.40 |
| ▸ | CA7 | P43166 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Water SCHEMBL8361961 | 0.98 | HSD17B3 (0.44) | HSD17B3PTPN1PTPN11HSP90AB1KDM4E | |
| Potassium Ion SCHEMBL851715 | 0.97 | HSD17B3 (0.45) | HSD17B3PTPN1PTPN11HSP90AB1KDM4E | |
| Zinc Ion SCHEMBL11170436 | 0.97 | HSD17B3 (0.45) | HSD17B3PTPN1PTPN11HSP90AB1KDM4E | |
| Paraben SCHEMBL3515235 | 0.92 | CA1 (0.53) | HSD17B3PTPN1PTPN11HSP90AB1KDM4E | |
| SCHEMBL2325181 | 0.90 | TYR (0.53) | HSP90AB1KDM4EHTTMAPTCA1 | |
| SCHEMBL344000 | 0.90 | TYR (0.53) | HSP90AB1KDM4EHTTMAPTCA1 | |
| SCHEMBL729988 | 0.87 | HSD17B1 (0.50) | HSD17B3HSP90AB1KDM4EHTTCA1 | |
| SCHEMBL5152452 | 0.87 | TYR (0.53) | HSD17B3HSP90AB1KDM4EHTTMAPT | |
| Potassium Ion SCHEMBL761984 | 0.87 | TYR (0.53) | HSD17B3HSP90AB1KDM4EHTTMAPT | |
| Potassium Ion SCHEMBL1012149 | 0.84 | HSD17B1 (0.50) | HSD17B3HSP90AB1KDM4EHTTCA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 3257 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120983376-B | Clofazimine soft capsule and preparation method thereof | SHANXI LIYE PHARMACEUTICAL Co.,Ltd. (CN) | 2026-05-26 | — | — | CN | claimed |
| EP-4743053-A1 | ANTIMICROBIAL SYNERGIES | Symrise AG (DE) | 2026-05-20 | — | — | EP | claimed |
| US-20260124120-A1 | STABILIZED AQUEOUS COMPOSITIONS CONTAINING HYDROXYAPTITE AND FREE IONS FOR IN VIVO REMINERALIZATION OF CALCIFIED TISSUE & THEIR METHODS OF USE | INTER MED INC (US) | 2026-05-07 | — | — | US | claimed |
| WO-2026088186-A1 | FERMENTED AND DEHYDRATED ALOE GEL PRODUCT AND PROCESS FOR THE PREPARATION THEREOF | YOSHAY IDO MOSHE (IL) | 2026-04-30 | — | — | WO | claimed |
| US-12595237-B2 | Lamotrigine hydrate crystal form, preparation method therefor, and composition containing same | SHANGHAI AUCTA PHARMACEUTICALS CO., LTD. (CN) | 2026-04-07 | — | — | US | claimed |
| EP-4554551-B1 | 3-HYDROXYPROPYLESTERS AS ANTIMICROBIAL AGENTS | SYMRISE AG (DE) | 2026-03-11 | — | — | EP | claimed |
| US-20260041094-A1 | Compositions Comprising an Antimicrobial Boosting Agent | SYMRISE AG (DE) | 2026-02-12 | — | — | US | claimed |
| EP-3843703-B1 | PARACETAMOL LIQUID SUSPENSIONS | HALEON CH SARL (CH) | 2025-11-05 | — | — | EP | claimed |
| WO-2025217640-A1 | COMPOSITIONS AND METHODS FOR TREATING METABOLIC DISEASES | ELI LILLY AND COMPANY (US) | 2025-10-16 | — | — | WO | claimed |
| EP-4628073-A1 | COMPOSITION CONTAINING TRETINOIN, PREPARATION METHOD THEREFOR, AND USE THEREOF | NANJING INDETEK LABORATORY CO., LTD. (CN) | 2025-10-08 | — | — | EP | claimed |
| US-6495148-B1 | HIGH MOLECULAR WEIGHT POLYURONIC ACIDS USED AS MOISTURIZERS AND FOR PREVENTION OF SKIN DISORDERS, ULCERS, WRINKLES, DRYNESS OR AGING | ABBIATI GIULIANA (IT) | 2002-12-17 | — | — | US | claimed |
| WO-2001089544-A1 | ANTIMIGRAINE COMBINATION COMPRISING SAPINDUS AND EMBLICA EXTRACTS | LUPIN LABORATORIES LIMITED (IN) | 2001-11-29 | — | — | WO | claimed |
| EP-1137671-A1 | REACTION PRODUCTS OF HYALURONIC ACID AND NATURAL AMINO ACIDS AND THEIR USE IN COSMETIC AND PHARMACEUTICAL COMPOSITIONS | Jasper Ltd. Liability Co. (US) | 2001-10-04 | — | — | EP | claimed |
| EP-0991704-A4 | PRODUCTION OF POLYORGANOPHOSPHAZENES HAVING DESIRED MOLECULAR WEIGHTS | AVANT IMMUNOTHERAPEUTICS INC (US) | 2000-08-30 | — | — | EP | claimed |
| CN-1256706-A | Non-drying adhesive composition for treating surfaces | HENKEL ECOLAB GMBH & CO OHG (DE) | 2000-06-14 | — | — | CN | claimed |
| EP-0991704-A1 | PRODUCTION OF POLYORGANOPHOSPHAZENES HAVING DESIRED MOLECULAR WEIGHTS | Avant Immunotherapeutics, Inc. (US) | 2000-04-12 | — | — | EP | claimed |
| WO-2000008061-A1 | REACTION PRODUCTS OF HYALURONIC ACID AND NATURAL AMINO ACIDS AND THEIR USE IN COSMETIC AND PHARMACEUTICAL COMPOSITIONS | JASPER LTD. LIABILITY CO. (US) | 2000-02-17 | — | — | WO | claimed |
| US-5869016-A | REACTING POLYDICHLOROPHOSPHAZENE AND NUCLEOPHILIC REAGENT TO PRODUCE SUBSTITUTED POLYORGANOPHOSPHAZENE, ADDING WATER | VIRUS RESEARCH INSTITUTE, INC. (US) | 1999-02-09 | — | — | US | claimed |
| WO-1998058014-A1 | PRODUCTION OF POLYORGANOPHOSPHAZENES HAVING DESIRED MOLECULAR WEIGHTS | AVANT IMMUNOTHERAPEUTICS, INC. (US) | 1998-12-23 | — | — | WO | claimed |
| EP-0506563-B1 | Suspension containing alginic acid | PF MEDICAMENT (FR) | 1995-01-04 | — | — | EP | claimed |